Effectiveness of the mRNA BNT162b2 vaccine against SARS-CoV-2 severe infections in the Israeli over 60 population: a temporal analysis done by using the national surveillance data
View ORCID ProfileStefano De Leo
doi: https://doi.org/10.1101/2021.09.27.21264130
Stefano De Leo
Department of Applied Mathematics, Campinas State University, Brazil
Data Availability
Data are available in the Tables of the paper.
Posted October 06, 2021.
Effectiveness of the mRNA BNT162b2 vaccine against SARS-CoV-2 severe infections in the Israeli over 60 population: a temporal analysis done by using the national surveillance data
Stefano De Leo
medRxiv 2021.09.27.21264130; doi: https://doi.org/10.1101/2021.09.27.21264130
Subject Area
Subject Areas
- Addiction Medicine (350)
- Allergy and Immunology (674)
- Anesthesia (181)
- Cardiovascular Medicine (2666)
- Dermatology (225)
- Emergency Medicine (404)
- Epidemiology (12278)
- Forensic Medicine (10)
- Gastroenterology (766)
- Genetic and Genomic Medicine (4132)
- Geriatric Medicine (387)
- Health Economics (682)
- Health Informatics (2677)
- Health Policy (1008)
- Hematology (364)
- HIV/AIDS (855)
- Medical Education (400)
- Medical Ethics (109)
- Nephrology (443)
- Neurology (3920)
- Nursing (212)
- Nutrition (583)
- Oncology (2056)
- Ophthalmology (591)
- Orthopedics (242)
- Otolaryngology (306)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1121)
- Primary Care Research (458)
- Public and Global Health (6556)
- Radiology and Imaging (1411)
- Respiratory Medicine (874)
- Rheumatology (413)
- Sports Medicine (344)
- Surgery (453)
- Toxicology (54)
- Transplantation (187)
- Urology (167)